Gene expression profiling for the purposes of biomarker discovery in oral potentially malignant lesions: a systematic review.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 3825664)

Published in Clin Med Insights Oncol on October 31, 2013

Authors

Ahmad A Abdulmajeed1, Camile S Farah

Author Affiliations

1: The University of Queensland, UQ Centre for Clinical Research, Herston, Queensland, Australia. ; The University of Queensland, School of Dentistry, Brisbane, Queensland, Australia.

Articles cited by this

Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer (1953) 11.45

Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res (2006) 9.87

IDconverter and IDClight: conversion and annotation of gene and protein IDs. BMC Bioinformatics (2007) 4.17

UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J Biol Chem (2002) 3.52

Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med (1999) 3.06

Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol (2008) 2.93

Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med (2008) 2.82

Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer (2006) 2.50

Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression. Mol Cell Biol (2004) 2.49

Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis. Cancer Res (2006) 2.36

Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheumatol (1992) 2.32

Identification of a major keratinocyte cell envelope protein, loricrin. Cell (1990) 2.25

Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1995) 2.09

Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics (2008) 2.09

Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: genome-wide gene-expression profiles of prostate cancers and PINs. Cancer Res (2004) 1.73

Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics. Oncogene (2006) 1.68

CXC chemokines in angiogenesis of cancer. Semin Cancer Biol (2004) 1.65

Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. Lancet Oncol (2006) 1.61

Gene expression profiling identifies genes predictive of oral squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2008) 1.60

Observer variability in the histologic assessment of oral premalignant lesions. J Oral Pathol Med (1995) 1.58

Predicting biomarkers for ovarian cancer using gene-expression microarrays. Br J Cancer (2004) 1.47

Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation. Am J Pathol (2002) 1.46

Association between gene expression profile and tumor invasion in oral squamous cell carcinoma. Cancer Genet Cytogenet (2004) 1.45

Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays. Cancer Res (2002) 1.44

Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis. Int J Cancer (2003) 1.41

Oral cancer. The importance of early diagnosis and treatment. Am J Clin Dermatol (2001) 1.37

Suprabasal 40 kd keratin (K19) expression as an immunohistologic marker of premalignancy in oral epithelium. Am J Pathol (1989) 1.36

Epithelial V-like antigen (EVA), a novel member of the immunoglobulin superfamily, expressed in embryonic epithelia with a potential role as homotypic adhesion molecule in thymus histogenesis. J Cell Biol (1998) 1.28

TKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1alpha stabilization. Clin Cancer Res (2010) 1.27

Increased EMMPRIN (CD 147) expression during oral carcinogenesis. Exp Mol Pathol (2005) 1.25

Immunohistological evaluation of Ki-67, p63, CK19 and p53 expression in oral epithelial dysplasias. J Oral Pathol Med (2006) 1.25

Transcriptional expression profiles of oral squamous cell carcinomas. Cancer (2002) 1.23

Gene expression profiling predicts the development of oral cancer. Cancer Prev Res (Phila) (2011) 1.13

Interobserver reliability in the histopathologic diagnosis of oral pre-malignant and malignant lesions. J Oral Pathol Med (2004) 1.12

Gene expression analysis, proteomics, and network discovery. Plant Physiol (2009) 1.09

Heparanase expression is an independent prognostic factor in patients with invasive cervical cancer. Ann Oncol (2003) 1.07

A transcriptional progression model for head and neck cancer. Clin Cancer Res (2003) 1.06

Usp18 regulates epidermal growth factor (EGF) receptor expression and cancer cell survival via microRNA-7. J Biol Chem (2011) 1.04

Cytokeratin alteration in oral leukoplakia and oral squamous cell carcinoma. Oncol Rep (2007) 1.01

Identification of a predictive gene expression signature of cervical lymph node metastasis in oral squamous cell carcinoma. Cancer Sci (2007) 1.00

Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue. Am J Pathol (1992) 1.00

Divergent routes to oral cancer. Cancer Res (2006) 0.99

Microarray analysis reveals that Type I interferon strongly increases the expression of immune-response related genes in Ubp43 (Usp18) deficient macrophages. Biochem Biophys Res Commun (2007) 0.99

Differential expression of the keratin-4, -13, -14, -17 and transglutaminase 3 genes during the development of oral squamous cell carcinoma from leukoplakia. Oral Oncol (2005) 0.99

Gene discovery in oral squamous cell carcinoma through the Head and Neck Cancer Genome Anatomy Project: confirmation by microarray analysis. Oral Oncol (2003) 0.99

Identification of genes and molecular pathways involved in the progression of premalignant oral epithelia. Mol Cancer Ther (2005) 0.98

Potential markers of tongue tumor progression selected by cDNA microarray. Int J Immunopathol Pharmacol (2005) 0.97

Calmodulin-like skin protein: a new marker of keratinocyte differentiation. J Invest Dermatol (2001) 0.95

Gene expression analysis by cDNA microarray in oral squamous cell carcinoma. J Oral Pathol Med (2006) 0.95

Antiproliferative activity of the human IFN-alpha-inducible protein IFI44. J Interferon Cytokine Res (2007) 0.95

Gene expression profiles in squamous cell carcinomas of the oral cavity: use of laser capture microdissection for the construction and analysis of stage-specific cDNA libraries. Oral Oncol (2000) 0.93

Expression of heparanase in oral cancer cell lines and oral cancer tissues. Oral Oncol (2001) 0.93

Gene expression profiling: decoding breast cancer. Surg Oncol (2009) 0.92

The methodology used to measure differential gene expression affects the outcome. J Biomol Tech (2007) 0.90

Meta-analysis of oncogenic protein kinase Ciota signaling in lung adenocarcinoma. Clin Cancer Res (2009) 0.90

A novel function of CXCL13 to stimulate RANK ligand expression in oral squamous cell carcinoma cells. Mol Cancer Res (2009) 0.90

Tissue-specific gene expression of head and neck squamous cell carcinoma in vivo by complementary DNA microarray analysis. Arch Otolaryngol Head Neck Surg (2003) 0.89

Gene expression signatures that can discriminate oral leukoplakia subtypes and squamous cell carcinoma. Oral Oncol (2006) 0.89

Gene expression of differentiation-specific keratins in oral epithelial dysplasia and squamous cell carcinoma. Oral Oncol (2001) 0.88

Discovery of novel biomarkers in oral submucous fibrosis by microarray analysis. Cancer Epidemiol Biomarkers Prev (2008) 0.88

Expression of 70-kDa heat shock protein in oral lesions: marker of biological stress or pathogenicity. Oral Oncol (1998) 0.87

Characterization of gene expression profiles of 3 different human oral squamous cell carcinoma cell lines with different invasion and metastatic capacities. J Oral Maxillofac Surg (2008) 0.87

Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorigenesis. Cancer Metastasis Rev (1996) 0.86

Calpain-mediated truncation of dihydropyrimidinase-like 3 protein (DPYSL3) in response to NMDA and H2O2 toxicity. J Neurochem (2005) 0.86

Gene expression profiling identifies Fibronectin 1 and CXCL9 as candidate biomarkers for breast cancer screening. Br J Cancer (2010) 0.86

BHLHB3: a candidate tumor suppressor in lung cancer. Oncogene (2008) 0.84

Activation of PI3K-AKT pathway in oral epithelial dysplasia and early cancer of tongue. Bull Tokyo Dent Coll (2009) 0.83

Genetic portrait of mild and severe lingual dysplasia. Oral Oncol (2005) 0.83

Gene expression profile in oral squamous cell carcinomas and matching normal oral mucosal tissues from black Africans and white Caucasians: the case of the Sudan vs. Norway. Oral Oncol (2003) 0.83

Role of CXC chemokine ligand 13 in oral squamous cell carcinoma associated osteolysis in athymic mice. Int J Cancer (2010) 0.83

The mRNA profile of genes in betel quid chewing oral cancer patients. Oral Oncol (2004) 0.82

Putative cancer stem cell marker expression in oral epithelial dysplasia and squamous cell carcinoma. J Oral Pathol Med (2013) 0.81

Expression profiling and prediction of distant metastases in head and neck squamous cell carcinoma. J Clin Pathol (2006) 0.81

Organotypic culture of normal, dysplastic and squamous cell carcinoma-derived oral cell lines reveals loss of spatial regulation of CD44 and p75 NTR in malignancy. J Oral Pathol Med (2012) 0.80

Risk prediction for malignant conversion of oral epithelial dysplasia by hypoxia related protein expression. Pathology (2013) 0.80

Cartilage oligomeric matrix protein expression in hepatocellular carcinoma and the cirrhotic liver. J Gastroenterol Hepatol (2004) 0.80

Gene expression changes in initiation and progression of oral squamous cell carcinomas revealed by laser microdissection and oligonucleotide microarray analysis. Int J Cancer (2012) 0.80

Heat shock proteins (HSP70 and HSP27) as markers of epithelial dysplasia in oral leukoplakia. Am J Dermatopathol (2006) 0.79

Gene expression profiles of oral leukoplakia and carcinoma: genome-wide comparison analysis using oligonucleotide microarray technology. Int J Oncol (2006) 0.79

Gene expression profiling of oral submucous fibrosis using oligonucleotide microarray. Oncol Rep (2008) 0.78

Gene expression analysis by oligonucleotide microarray in oral leukoplakia. J Oral Pathol Med (2009) 0.78

Gene expression profiling of oral squamous cell carcinoma using laser microdissection and cDNA microarray. Med Electron Microsc (2004) 0.78

Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia. Ann Diagn Pathol (2013) 0.76

Articles by these authors

Innate versus adaptive immunity in Candida albicans infection. Immunol Cell Biol (2004) 1.22

Th1 cytokines in oral lichen planus. J Oral Pathol Med (2003) 1.14

Role of complement C5 and T lymphocytes in pathogenesis of disseminated and mucosal candidiasis in susceptible DBA/2 mice. Microb Pathog (2003) 1.05

Bisphosphonate-related osteonecrosis of the jaws: a comprehensive review. J Oral Pathol Med (2007) 1.03

Cancer stem cell markers in head and neck squamous cell carcinoma. Stem Cells Int (2013) 0.97

Combined topical and systemic clonazepam therapy for the management of burning mouth syndrome: a retrospective pilot study. J Orofac Pain (2011) 0.88

MicroRNAs in Head and Neck Cancer. Int J Dent (2013) 0.88

High specificity of combined narrow band imaging and autofluorescence mucosal assessment of patients with head and neck cancer. Head Neck (2012) 0.83

Expression of ABCG2 and Bmi-1 in oral potentially malignant lesions and oral squamous cell carcinoma. Cancer Med (2014) 0.82

Testing the educational potential of 3D visualization software in oral radiographic interpretation. J Dent Educ (2011) 0.82

The assessment of diffused light illumination and acetic acid rinse (Microlux/DL) in the visualisation of oral mucosal lesions. Oral Oncol (2009) 0.82

Putative cancer stem cell marker expression in oral epithelial dysplasia and squamous cell carcinoma. J Oral Pathol Med (2013) 0.81

Effector function of leucocytes from susceptible and resistant mice against distinct isolates of Candida albicans. Immunol Cell Biol (2006) 0.80

Organotypic culture of normal, dysplastic and squamous cell carcinoma-derived oral cell lines reveals loss of spatial regulation of CD44 and p75 NTR in malignancy. J Oral Pathol Med (2012) 0.80

Smg1 haploinsufficiency predisposes to tumor formation and inflammation. Proc Natl Acad Sci U S A (2012) 0.80

Advances in optical adjunctive AIDS for visualisation and detection of oral malignant and potentially malignant lesions. Int J Dent (2013) 0.79

Perspective: Electronic systems of knowledge in the world of virtual microscopy. Acad Med (2009) 0.79

Accelerated wound healing phenotype in Interleukin 12/23 deficient mice. J Inflamm (Lond) (2011) 0.78

Heightened risk of second primary carcinoma of the head and neck following cervical neoplasia. Head Neck (2013) 0.76

A retrospective analysis of clinical features of oral malignant and potentially malignant disorders with and without oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol (2013) 0.76

Canine transmigration: comprehensive literature review and report of 4 new Australian cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2010) 0.76

Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia. Ann Diagn Pathol (2013) 0.76

Can immunohistochemistry serve as an alternative to subjective histopathological diagnosis of oral epithelial dysplasia? Biomark Cancer (2013) 0.76

Focus On: Oral Cancer Screening Devices. Dent Today (2017) 0.75

Carcinoma ex pleomorphic adenoma in a minor salivary gland of the upper lip. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2009) 0.75

Assessment of oral mucosal lesions with autofluorescence imaging and reflectance spectroscopy. J Am Dent Assoc (2016) 0.75

Intra-oral calibre persistent artery. J Craniomaxillofac Surg (2009) 0.75

The assessment of the DNA content of oral cytology via virtual microscopy for the early detection of epithelial dysplasia and neoplasia in oral mucosal lesions. Oral Oncol (2009) 0.75

Combining autofluorescence and narrow band imaging with image analysis in the evaluation of preneoplastic lesions in the bronchus and larynx. J Bronchology Interv Pulmonol (2010) 0.75

Dental prosthetist experience with oral mucosal screening and referral. Quintessence Int (2014) 0.75